Table1:
Subject characteristics,
tests availability and basic date of the subject.
|
|
Inclusion |
Monthly |
End of study OC vs. Non OC |
Study group OC vs. Non OC |
|
Subjects* OC vs. Non OC |
19 vs. 29 |
|
15 (13 combined, 1 antiandrogen, 1 gestagen), vs. 18 |
|
|
Age |
18 - 35 yrs
|
|
23 ± 3 yrs
vs. 26 ± 4 yrs |
p = 0.006 |
|
Weight |
yes |
yes |
61 ± 6 kg vs. 67 ± 13 kg |
p = 0.012 |
|
Height |
yes |
|
1.66 ± 0.06 m vs. 1.68 ± 0.07
m |
n.s. |
|
VO2max (ml/kg*
min) |
50.0 ± 4.7 vs. 46.4 ± 4.6 |
|
49.9 ± 5.0 vs. 45.3 ± 6.1 |
Inclusion p = 0.037 End of study p = 0.040 |
|
Oxytocin |
yes |
yes |
yes |
|
|
POMS |
yes |
yes |
Yes |
|
|
Menstrual cycle day |
yes |
yes |
Yes |
|
|
Training load** |
> 3 h/w at > Borg 13 |
yes |
15 ± 2 vs. 15 ± 2 |
n.s. |
*Reason for becoming a discontinuer: absence
> 2 consecutive tests (n = 5), other reasons (n = 4), changing OC use (n =
5), pregnancy (n = 1); **Borg, 1970; (58) (57), 7 on the training intensity
scale in the POMS questionnaire.